Silofast (Rapaflo)8 Mg – 15 tablet

USD $22.43

Each Silofast contains 8 mg Silodosin 15 tablets used to treat benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland.

ATC Classification: G04CA04
Active Ingrediant: Silodosin
Generic Name: Silofast
Manufacturer: Cipla Limited
Strength: 8 Mg
Dosage Type: Capsule
Packaging Type: Foil in Box
Contains: 15 Caps

Examples of Packages sent


Medication Safety Issues

Sound-alike/look-alike issues:

Rapaflo may be confused with Rapamune

Silodosin may be confused with sildenafil, sirolimus



Store at room temperature of 25?C (77?F); excursions permitted to 15?C to 30?C (59?F to 86?F). Protect from light. Protect from moisture.


Adverse Reactions

>10%: Genitourinary: Retrograde ejaculation (28%)

1% to 10%:

Cardiovascular: Orthostatic hypotension (3%; increased in elderly ?65 years up to 5%)

Central nervous system: Dizziness (3%), headache (2%), insomnia (1% to 2%)

Gastrointestinal: Diarrhea (3%), abdominal pain (1% to 2%)

Genitourinary: Prostate specific antigen increased (1% to 2%)

Neuromuscular & skeletal: Weakness (1% to 2%)

Respiratory: Nasal congestion (2%), rhinorrhea (1% to 2%), sinusitis (1% to 2%)

<1%, postmarketing, and/or case reports: Hepatic insufficiency, hypersensitivity reaction, increased serum transaminases, intraoperative floppy iris syndrome, jaundice, pharyngeal edema, priapism, pruritus, purpura, skin rash (including toxic), swollen tongue, syncope, urticaria

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , ,


Dosage Type

Packaging Type




There are no reviews yet.

Be the first to review “Silofast (Rapaflo)8 Mg – 15 tablet”

Your email address will not be published. Required fields are marked *